October 5, 2015: Morning Session
Obesity, Metabolism, and the Lung
8:00 – 9:00
Evangelos Michelakis, MD
The Interface Between Metabolism and the Pulmonary Vasculature
University of Alberta
9:00 – 9:45
Janice B. Allen, Ph.D.
The Emerging Role of Environmental Exposures in the Obesity/Asthma
Axis
National Institute of Environmental Health Sciences
Break
10:15 – 11:00
Kelan Tantisira, MD
Circulating miRNA in Asthma and Obesity
Harvard Medical School
11:00 – 11:45
Benjamin Marsland, PhD
Implication of Host-Microbe Interactions in Development of Respiratory
Diseases
University of Lausanne
11:45 – 12:30
Stephanie Shore, PhD
Obesity and Asthma: Microbiome-Metabolome Interactions
Harvard School of Public Health
Lunch (12:30 – 1:30)
1
October 5, 2015: Afternoon Session
Obesity and Airway Disease
1:30 – 2:10
Meredith McCormack, MD
Obesity, Diet and Airway Disease
Johns Hopkins University
2:10 – 2:50
Deepa Rastoogi, MD
Metabolic Dysregulation and Pediatric Obesity-Related Asthma
Albert Einstein College of Medicine
2:50 – 3:30
Fernando Holguin, MD
Obesity, Metabolic Dysregulation and Airway Oxidative Stress
University of Pittsburgh
Break
3:50 – 4:30
Jason Bates, PhD
The Mechanical Consequences of Obesity on Airways Responsiveness
University of Vermont
4:30 – 5:10
Anne Dixon, MA BM BCh
Phenotypes of Asthma in Obesity
University of Vermont
2
October 6, 2015: Morning Session
Mitochondria and Metabolism in Lung Disease I
8:00 – 8:45
Manu Jain, MD
Mitochondrial Reactive Oxygen Species Regulate TGF-β Signaling
Northwestern University Feinberg School of Medicine
8:45 – 9:00
Selected Abstract Talk
9:00 – 9:45
Stephen Black, PhD
Role of the Mitochondrion in Pulmonary Vascular Disease
Georgia Regents University
Break
10:15 – 11:00
Augustine Choi, MD
Mitochondrial Dysfunction: Regulator of Inflammation and Cell Death in
Lung Disease
Weill Cornell Medical College
11:00 – 11:15
Selected Abstract Talk
11:15 – 12:00
Ana Mora, MD
Dysfunctional Mitochondria in Lung Fibrosis
University of Pittsburgh
Lunch (12:00 – 1:00)
3
October 6, 2015: Afternoon Session
Mitochondria and Metabolism in Lung Disease II
1:00-1:15
Selected Abstract Talk
1:15 – 2:00
Viswanathan Natarajan, PhD
Lysocardiolipin, a Mitochondrial Cardiolipin Remodeling Enzyme, in the
Pathogenesis of Pulmonary Fibrosis
University of Illinois at Chicago
2:00 – 2:45
Abstract Talk
Poster Discussion and Reception (2:45 – 5:00)
4
October 7, 2015: Morning Session
Lipid Handling and Mishandling: Effects on Lung Inflammation and Remodeling
8:00 - 8:40
Benjamin Suratt, MD
Hypercholesterolemia and the ‘Priming’ of the Lung for Disease
University of Vermont College of Medicine
8:40 - 9:20
Ross Summer, MD
Dysregulated Lipid Synthesis Promotes Fibrotic Responses in the Lung
Thomas Jefferson University
9:20 - 10:00
Michael Fessler, MD
A Novel Role for Oxysterols in Resolution of Lung Inflammation and
Critical Illness
National Institute of Environmental Health Sciences
Break
10:20 - 11:00
Yury Miller, MD, PhD
Targeted Cholesterol Efflux and Inflammation
University of California, San Diego
11:00 – 11:40
Konstantin Birukov, MD, PhD
Oxidized Phospholipids in Lung Injury and Inflammation: Friend or Foe?
The University of Chicago
11:40 – 12:20
Irina Petrache, MD
Metabolic Derangements in COPD
National Jewish Health
Lunch & Conference Summary (12:20 – 1:20)
5